The Structural and Functional Journey of Apolipoprotein A-I Through the Human Body.
Level 5 - mechanism / opinion, no new human data
Narrative review detailing biological and structural mechanisms without primary human data or systematic synthesis.
PubMed 42012553 · doi:10.1007/s11883-026-01405-3
What was done
This narrative review summarizes recent structural biology and physiological literature examining the lifecycle of apolipoprotein A-I (APOA1). It traces APOA1 from synthesis and early lipid-free states through high-density lipoprotein (HDL) assembly, particle remodeling, lymphatic transit, immune modulation, and final clearance or recycling.
What was found
The abstract reports no quantitative metrics or numerical findings. It qualitative describes that transitional conformations of APOA1 govern interactions with lipid transporters, enzymes, and receptors, suggesting that the initial lipid-free conformation is a primary determinant of mature HDL particle function and metabolic adaptation.
Why it matters
Understanding the structural dynamics of APOA1 clarifies how HDL mediates reverse cholesterol transport and inflammatory protection, pointing to structural targets for cardiovascular disease therapeutics.
Limits
As a narrative review, the paper presents no original experimental data, systematic methodology, or quantitative clinical outcomes. Technical limitations noted include persistent gaps in characterizing specific structural conformations on lipid surfaces and translating findings in human-relevant models.
Cited by
- supports ApoA apolipoproteins wrap the high-density lipoprotein (HDL) family of particles.